JPWO2022019325A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022019325A5
JPWO2022019325A5 JP2022538037A JP2022538037A JPWO2022019325A5 JP WO2022019325 A5 JPWO2022019325 A5 JP WO2022019325A5 JP 2022538037 A JP2022538037 A JP 2022538037A JP 2022538037 A JP2022538037 A JP 2022538037A JP WO2022019325 A5 JPWO2022019325 A5 JP WO2022019325A5
Authority
JP
Japan
Prior art keywords
acid sequence
derived
cells
ability
bone marrow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022538037A
Other languages
English (en)
Japanese (ja)
Other versions
JP7774807B2 (ja
JPWO2022019325A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/027279 external-priority patent/WO2022019325A1/ja
Publication of JPWO2022019325A1 publication Critical patent/JPWO2022019325A1/ja
Publication of JPWO2022019325A5 publication Critical patent/JPWO2022019325A5/ja
Priority to JP2025185750A priority Critical patent/JP2026027332A/ja
Application granted granted Critical
Publication of JP7774807B2 publication Critical patent/JP7774807B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022538037A 2020-07-22 2021-07-21 栄養障害型表皮水疱症の治療薬 Active JP7774807B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025185750A JP2026027332A (ja) 2020-07-22 2025-11-04 栄養障害型表皮水疱症の治療薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020125620 2020-07-22
JP2020125620 2020-07-22
PCT/JP2021/027279 WO2022019325A1 (ja) 2020-07-22 2021-07-21 栄養障害型表皮水疱症の治療薬

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025185750A Division JP2026027332A (ja) 2020-07-22 2025-11-04 栄養障害型表皮水疱症の治療薬

Publications (3)

Publication Number Publication Date
JPWO2022019325A1 JPWO2022019325A1 (https=) 2022-01-27
JPWO2022019325A5 true JPWO2022019325A5 (https=) 2024-07-29
JP7774807B2 JP7774807B2 (ja) 2025-11-25

Family

ID=79729198

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022538037A Active JP7774807B2 (ja) 2020-07-22 2021-07-21 栄養障害型表皮水疱症の治療薬
JP2025185750A Pending JP2026027332A (ja) 2020-07-22 2025-11-04 栄養障害型表皮水疱症の治療薬

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025185750A Pending JP2026027332A (ja) 2020-07-22 2025-11-04 栄養障害型表皮水疱症の治療薬

Country Status (5)

Country Link
US (1) US20240050481A1 (https=)
JP (2) JP7774807B2 (https=)
KR (1) KR20230043906A (https=)
AU (1) AU2020459825A1 (https=)
WO (2) WO2022018884A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025094280A (ja) * 2022-01-21 2025-06-25 国立大学法人大阪大学 細胞シート
CN118001404B (zh) * 2024-02-06 2025-02-25 四川大学华西医院 抑制C17orf67基因表达试剂在制备治疗获得性大疱表皮松解症药物中的用途
KR102736437B1 (ko) * 2024-06-20 2024-12-02 주식회사 에이바이오테크 콜라겐 합성 촉진 활성을 갖는 콜라겐 타입 7 저분자 펩타이드 및 이를 이용한 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7159048B2 (ja) 2016-01-04 2022-10-24 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法
KR20180118795A (ko) * 2016-03-18 2018-10-31 인트렉손 코포레이션 Vii형 콜라겐 결핍증의 치료를 위한 조성물 및 방법
WO2018154413A1 (en) 2017-02-22 2018-08-30 Crispr Therapeutics Ag Materials and methods for treatment of dystrophic epidermolysis bullosa (deb) and other collagen type vii alpha 1 chain (col7a1) gene related conditions or disorders
WO2018235834A1 (ja) * 2017-06-19 2018-12-27 国立大学法人北海道大学 表皮水疱症の治療剤
MX2020002777A (es) * 2017-09-22 2020-09-17 Univ Miami Metodos y composiciones para tratamiento de epidermolisis ampollosa.
JP7141079B2 (ja) * 2018-02-22 2022-09-22 学校法人順天堂 栄養障害型表皮水疱症治療剤
KR20210116531A (ko) * 2019-01-18 2021-09-27 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 영양 장애형 표피 수포증 치료약

Similar Documents

Publication Publication Date Title
JPWO2022019325A5 (https=)
Ansari et al. Human periodontal ligament‐and gingiva‐derived mesenchymal stem cells promote nerve regeneration when encapsulated in alginate/hyaluronic acid 3D scaffold
Nardi et al. Mesenchymal stem cells: isolation, in vitro expansion and characterization
Orbay et al. Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications
Liu et al. Concise reviews: Characteristics and potential applications of human dental tissue-derived mesenchymal stem cells
Liu et al. Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy
Dissanayaka et al. Characterization of dental pulp stem cells isolated from canine premolars
JP2011525798A5 (https=)
JP2016523285A5 (https=)
Zhang et al. Bone tissue regeneration-application of mesenchymal stem cells and cellular and molecular mechanisms
JP2015507921A5 (https=)
Elhusseini et al. Long term study of protective mechanisms of human adipose derived mesenchymal stem cells on cisplatin induced kidney injury in sprague-dawley rats
JPWO2020149395A5 (https=)
CN111979187A (zh) 一种抗人间充质干细胞衰老及增强其干性特征的方法
Didilescu et al. Dental pulp as a stem cell reservoir
Okić-Đorđević et al. Dental mesenchymal stromal/stem cells in different microenvironments—implications in regenerative therapy
Zhou et al. Dental mesenchymal stem cells in inflamed microenvironment: potentials and challenges for regeneration
JP2020537539A5 (https=)
Krishnan et al. Mesenchymal stem cells from orthodontic premolar teeth
Feter et al. Dental mesenchymal stem cell: Its role in tooth development, types, surface antigens and differentiation potential
CN110894488A (zh) 全反式维甲酸在间充质干细胞分化调节中的应用
Pan et al. Alternating 2D and 3D culture reduces cell size and extends the lifespan of placenta-derived mesenchymal stem cells
RU2019102933A (ru) Лечение сосудистого заболевания сетчатки с использованием клеток-предшественников
Su et al. Cartilage-derived stromal cells: is it a novel cell resource for cell therapy to regenerate infarcted myocardium?
El-Derby et al. Adult stem cells: mesenchymal stromal cells, endothelial progenitor cells, and pericytes